NewsBenzinga武田药品工业株式会社将2026财年核心每股收益指引从472日元上调至482日元；将2026财年营收指引从4.64万亿日元上调至4.70万亿日元 武田药品工业株式会社将2026财年核心每股收益指引从472日元上调至482日元；将2026财年营收指引从4.64万亿日元上调至4.70万亿日元 Benzinga 2026.10.29 07:57 (GMT+0) Open on Benzinga Other news Putin Calls Musk a 'Real Genius' as Russia Races to Build Starlink Rival Amid Ukraine War Piper Sandler Reiterates Overweight on ServiceNow, Maintains $175 Price Target Obama Says Trump Administration Mobilized ‘Whole-of-Government Response’ to Cheesecake Factory Joke Instead of Inflation: ‘Not Serious People’ Piper Sandler Reiterates Overweight on Microsoft, Raises Price Target to $650 YPF Q3 EPS $0.30, Sales $6.557B Portland Gen Electric Q3 Adj. EPS $1.06 Misses $1.11 Estimate, Sales $969.000M Miss $1.031B Estimate
Obama Says Trump Administration Mobilized ‘Whole-of-Government Response’ to Cheesecake Factory Joke Instead of Inflation: ‘Not Serious People’
